Source: Virtual Congress 2020 – Conventional bronchoscopy
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
L. Morandi (Ferrara (FE), Italy), A. Papi (Ferrara (FE), Italy), F. Torsani (Ferrara (FE), Italy), R. Roncarati (Ferrara (FE), Italy), L. Lupini (Ferrara (FE), Italy), M. Negrini (Ferrara (FE), Italy), G. Casoni (Rovigo (RO), Italy). Molecular testing with Next Generation Sequencing on Bronchial Lavage from patients with suspect lung cancer. 2834

Member's Comments

No comment yet.

Related content which might interest you: Surfactant changes in patients with lung cancer underwent to resection Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 Potential lung cancer biomarkers from bronchoalveolar lavage fluid using metabolomics approaches Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Immunohistochemistry versus DNA testing for detection of EGFR mutations and ALK rearrangements in lung adenocarcinoma patients Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases Year: 2014 Detection of exosomal miRNA in pulmonary sarcoidosis Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine Year: 2014 Metabolomic profiling of clinical sputum samples reveals novel biomarkers for the early identification of lung cancer patients Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Induced sputum in the diagnosis of lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 299s Year: 2004 Comparative analysis of lung cancer driver mutations from FFPE samples and liquid biopsies by IonTorrent next generation sequencing Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 Serum and bronchial aspiration fluid HE-4 levels in lung cancer Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Dividing EBUS-TBNA samples for simultaneous histopathological and molecular analyses in lung cancer patients Source: International Congress 2015 – Endoscopic ultrasound: an essential tool for interventional pulmonology Year: 2015 Genetic mutations in transbronchial lung biopsy of peripheral lesions Source: International Congress 2016 – Transbronchial diagnostics: from ILD to pheripheral lesions Year: 2016 Prevalence of preinvasive bronchial lesions in patients with lung cancer Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies Year: 2013 Molecular analysis of peripheral non-squamous non-small cell lung cancer sampled by radial EBUS Source: International Congress 2016 – Endosonography: EBUS/EUS (B) Year: 2016 Prevalence of molecular changes in resected pulmonary adenocarcinomas Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 High-throughput detection of alternative splicing in patients with non-small cell lung cancer treated by bevacizumab/erlotinib Source: International Congress 2014 – Novel approaches in transcriptomics and epigenomics in inflammatory lung diseases and lung cancer Year: 2014 Early detection of lung cancer in exhaled breath condensate using miRNA markers Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 Circulating biomarkers and tumour molecular profiling in patients with non-small cell lung cancer Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 Allele-specific real-time PCR detection of EGFR exon 19 and 21 mutations in various clinical non-small cell lung cancer specimens Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases Year: 2014 Molecular biomarkers for lung adenocarcinoma Source: Eur Respir J , 49 (4)  1601734; DOI: 10.1183/13993003.01734-2016 Year: 2017 Pleural eicosanoids in patients with lung cancer Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013 Optimization of cfDNA routine use for NSCLC genomic alteration analysis Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease Year: 2016